EA200800101A1 - APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - Google Patents
APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASESInfo
- Publication number
- EA200800101A1 EA200800101A1 EA200800101A EA200800101A EA200800101A1 EA 200800101 A1 EA200800101 A1 EA 200800101A1 EA 200800101 A EA200800101 A EA 200800101A EA 200800101 A EA200800101 A EA 200800101A EA 200800101 A1 EA200800101 A1 EA 200800101A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- application
- neurodegenerative diseases
- adrenoreceptor agonists
- clenbuterol
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Заявлено применение кленбутерола - агониста β-адренорецепторов для восстановления и/или поддержания функции частично или полностью поврежденных/дегенерированных клеток в центральной нервной системе и/или других нервных клеток. Применение кленбутерола приводит к активации астроцитов и инициации эндогенных процессов нейрозащиты, причем оно может таким образом уменьшать и в некоторых случаях даже предупреждать повреждение или деструкцию нервных клеток.Clenbuterol, a β-adrenergic receptor agonist, is claimed to restore and / or maintain the function of partially or fully damaged / degenerated cells in the central nervous system and / or other nerve cells. The use of clenbuterol leads to the activation of astrocytes and the initiation of endogenous processes of neuroprotection, and it can thus reduce and in some cases even prevent damage or destruction of nerve cells.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10142175A DE10142175A1 (en) | 2001-10-09 | 2001-08-29 | Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases |
DE10142176A DE10142176A1 (en) | 2001-08-29 | 2001-08-29 | Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases |
DE10142178A DE10142178A1 (en) | 2001-08-29 | 2001-08-29 | Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases |
DE10149611A DE10149611A1 (en) | 2001-08-29 | 2001-10-09 | Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200800101A1 true EA200800101A1 (en) | 2008-06-30 |
Family
ID=40863263
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400356A EA200400356A1 (en) | 2001-08-29 | 2002-08-22 | APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
EA200800101A EA200800101A1 (en) | 2001-08-29 | 2002-08-22 | APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400356A EA200400356A1 (en) | 2001-08-29 | 2002-08-22 | APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
Country Status (1)
Country | Link |
---|---|
EA (2) | EA200400356A1 (en) |
-
2002
- 2002-08-22 EA EA200400356A patent/EA200400356A1/en unknown
- 2002-08-22 EA EA200800101A patent/EA200800101A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200400356A1 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9712086A (en) | Metalloproteinase1,4-heterocyclic inhibitors | |
ATE234092T1 (en) | 2-ALKYLPYRROLIDINE | |
ID26033A (en) | METHOD OF STABILIZATION OF PHARMACEUTICAL COMPOSITION MATERIALS WITH SPECIFIC USE OF ANTIOXIDE | |
ATE353640T1 (en) | ANTAGONISTS FOR THE TREATMENT OF CD11/CD18 ADHESION RECEPTOR-MEDIATED DISEASES | |
DK1583541T3 (en) | Compounds and Methods to Increase Neurogenesis | |
TR200001954T2 (en) | Indole derivatives as inhibitors of factor XA. | |
DK0912176T3 (en) | Use of pyridylalkane, pyridylalkene and / or pyridylalkynic acid amides for the treatment of tumors or immunosuppression | |
ATE428785T1 (en) | ACTIVE AND INACTIVE CC CHEMOKINE RECEPTORS AND NUCLEIC ACID MOLECULES THAT CODE FOR THIS RECEPTOR | |
ATE358510T1 (en) | DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICATION THROUGH THE EYELID | |
ATE362468T1 (en) | N-SUBSTITUTED INDOLES WITH APPLICATION IN THE TREATMENT OF DIABETES | |
ATE324090T1 (en) | ORTHOPICAL DEVICE FOR CORRECTING TOE MISPOINTMENTS | |
EA199800772A1 (en) | Derivatives of 6-phenylpyridyl-2-amine | |
EA200200647A1 (en) | Β2-adrenergic receptor agonists | |
ATE325119T1 (en) | 3-SUBSTITUTED OXINDOLE BETA-3 AGONISTS | |
PT1379203E (en) | CONDOM WITH AN ERGONOMIC COMPOSITION | |
PT1267869E (en) | METABOTROPIC GLUTAMATE RECEPTOR ANTOGONISTS FOR THE TREATMENT OF TOLERANCE AND DEPENDENCE | |
HUP0203837A2 (en) | Body weight gain inhibitors | |
ATE235422T1 (en) | GELATION-STABLE POLYHALOGENPHOSPHAZENE COMPOUNDS | |
EA200800101A1 (en) | APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
TR200101149T2 (en) | Treatment of external retinal disorders. | |
DK0996435T3 (en) | Amino acid derivatives useful for the treatment of stroke | |
PT1000046E (en) | ACTIVE PIPERAZINE DERIVATIVES IN LOWER URINARY TRACT | |
DK1342410T3 (en) | Use of a galanin agonist for the manufacture of a drug to improve memory and other cognitive functions | |
DK1056467T3 (en) | Method of treating diseases or disorders of the inner ear | |
NO20062778L (en) | Solid amorphous dispersions of an MTP inhibitor for the treatment of obesity |